Principal Financial Group
CTKB icon

Principal Financial Group’s Cytek Biosciences CTKB Stock Holding History

Principal Financial Group’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-534,759
Closed -$2.34M – 2182
2026
Q1 		$2.34M Sell
534,759
-132,168
-20% -$624K ﹤0.01% 1805
2025
Q4 		$3.37M Buy
666,927
+43,621
+7% +$203K ﹤0.01% 1734
2025
Q3 		$2.16M Buy
623,306
+50,919
+9% +$191K ﹤0.01% 1801
2025
Q2 		$1.95M Buy
572,387
+51,644
+10% +$172K ﹤0.01% 1806
2025
Q1 		$2.09M Buy
520,743
+13,818
+3% +$71.6K ﹤0.01% 1761
2024
Q4 		$3.29M Buy
506,925
+3,753
+0.7% +$22.4K ﹤0.01% 1703
2024
Q3 		$2.79M Buy
503,172
+23,028
+5% +$131K ﹤0.01% 1720
2024
Q2 		$2.68M Sell
480,144
-38,550
-7% -$232K ﹤0.01% 1715
2024
Q1 		$3.48M Sell
518,694
-31,729
-6% -$251K ﹤0.01% 1684
2023
Q4 		$5.02M Sell
550,423
-8,123
-1% -$51.1K ﹤0.01% 1554
2023
Q3 		$3.08M Buy
558,546
+82,456
+17% +$661K ﹤0.01% 1675
2023
Q2 		$4.07M Buy
476,090
+433,065
+1,007% +$3.88M ﹤0.01% 1612
2023
Q1 		$395K Sell
43,025
-4,621
-10% -$49.7K ﹤0.01% 2026
2022
Q4 		$486K Buy
47,646
+1,634
+4% +$22K ﹤0.01% 1983
2022
Q3 		$678K Sell
46,012
-52,388
-53% -$680K ﹤0.01% 1902
2022
Q2 		$1.06M Buy
98,400
+82,510
+519% +$821K ﹤0.01% 1909
2022
Q1 		$171K Buy
+15,890
New +$215K ﹤0.01% 2364

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Principal Financial Group's CTKB Position: Q2 2026 in Review

Principal Financial Group sold out of Cytek Biosciences (CTKB) in Q2 2026, closing a stake of 534,759 shares — an estimated $2.34M sold.

Principal Financial Group first reported a position in CTKB in Q1 2022 and held it in 17 quarters. The position peaked at $5.02M in Q4 2023. 155 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Principal Financial Group reported no remaining Cytek Biosciences position as of Q2 2026 after selling out during the quarter.
  • Principal Financial Group sold 534,759 Cytek Biosciences shares in Q2 2026, an estimated $2.34M.
  • Principal Financial Group first reported a position in Cytek Biosciences in Q1 2022 and held it in 17 quarters.
  • Principal Financial Group's Cytek Biosciences position peaked at $5.02M in Q4 2023.
  • 155 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.